Pre-Filled Syringes West Coast Conference 2024

June 10 - 11, 2024 - CA US

SAE Media Group

SAE Media Group's 8th Annual Pre-Filled Syringes West Coast Conference will be back for 2024 in the West Coast to bring together device developers, biotech and big pharma. This year's conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation. As part of SAE's leading injectable drug delivery conferences this is a must attend event; not only will the conference bring you key insights to enhance your drug device portfolio, but it will also give you the opportunity to network with key industry players. We hope to welcome you in June 2024! What will you gain? - Engage in discussions on evolving EU and US regulations as well as reviewing the latest FDA guidance on human factors and drawing insights from successful notified body opinions for streamlined regulatory compliance. - Gain insight into advancements in large volume drug delivery devices with a case study from Halozyme and a panel discussion assessing key considerations, benefits and barriers of such devices for stakeholders including patients, HCPs and pharma companies. - Delve into comprehensive strategies for maximizing combination product manufacturing and effectively managing your product's lifecycle with key insights from GSK and Merck - Acquire insights into human factors best practices from AbbVie and Regeneron, and discover ways to effectively apply testing and validation approaches for combination products. - Explore collaborative opportunities to advance innovation in the injectables field and gain insight into the latest technology updates and challenges these pose such as leaching in electro-mechanical devices. Speakers include: - Wenjing Wang, Associate Principal Scientist, Merck - Speaker to be confirmed, Regeneron - Paul Upham, Head Smart Devices, Genentech/ Roche - Ram Halthore, Head of Medical Devices and Combination Products Technical Operations, Merck - Li-Chun, Director, Global Device Engineering and Technologies, GSK - Kim VaanCuren, Sr. Principal Human Factors Engineer, AbbVie - Marie Printz, Executive Director, Halozyme - Jian Liu, Process Development Principal Scientist, Amgen - Kinsuk Shah, Sr. AD - Combination Product Steward, Boehringer Ingelheim - Abhi Raj, Senior Director, Device Development, AstraZeneca - Mitch Zhao, Engineering Director, Janssen - Hemanth Amarchinta, Director, Device Engineering, Protagonist Therapeutics Time: 8:00 AM - 5:00 PM

More Information